MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

Phase 2

Completed

Conditions: Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions: Drug: Dexamethasone
Drug: Lenalidomide
Drug: Pomalidomide

First Posted Date: 2013-02-18

Last Posted Date: 2018-08-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 9

Registration Number: NCT01794039

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

RCT of the Double Wire Technique for Sphincterotomy

Not Applicable

Terminated

Conditions: Cholangiopancreatography, Endoscopic Retrograde
Sphincterotomy, Endoscopic
VATER'S AMPULLA

Interventions: Procedure: Transpancreatic sphincterotomy

First Posted Date: 2013-02-15

Last Posted Date: 2017-07-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 16

Registration Number: NCT01792466

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy

Early Phase 1

Completed

Conditions: Stage IV Skin Melanoma

Interventions: Other: Laboratory Biomarker Analysis
Procedure: Radionuclide Imaging
Biological: Technetium Tc 99 Hydrazinonicotinamide-Tricine-linked Interleukin-2

First Posted Date: 2013-02-12

Last Posted Date: 2019-08-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 5

Registration Number: NCT01789827

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Procalcitonin Use in Pneumonia Patients in the Critical Care Setting

Not Applicable

Completed

Conditions: Pneumonia

Interventions: Other: Use of procalcitonin as biomarker to guide therapy

First Posted Date: 2013-02-11

Last Posted Date: 2013-06-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 134

Registration Number: NCT01788488

Locations: 🇺🇸
Mayo Clinic Health System Eau Claire, Eau Claire, Wisconsin, United States

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Not Applicable

Recruiting

Conditions: Enteropathy-Associated T-Cell Lymphoma
Mediastinal (Thymic) Large B-Cell Lymphoma
Anaplastic Large Cell Lymphoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Refractory Anaplastic Large Cell Lymphoma
Aggressive Non-Hodgkin Lymphoma
Angioimmunoblastic T-Cell Lymphoma
Hepatosplenic T-Cell Lymphoma
Nasal Type Extranodal NK/T-Cell Lymphoma

Interventions: Dietary Supplement: Cholecalciferol
Other: Laboratory Biomarker Analysis

First Posted Date: 2013-02-08

Last Posted Date: 2025-05-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 500

Registration Number: NCT01787409

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

and more 2 locations

LIPS-B: Lung Injury Prevention Study With Budesonide and Beta

Phase 2

Completed

Conditions: Acute Respiratory Distress Syndrome (ARDS)

Interventions: Drug: Budesonide
Drug: Placebo
Drug: Formoterol

First Posted Date: 2013-02-05

Last Posted Date: 2016-09-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 61

Registration Number: NCT01783821

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States

and more 2 locations

Dent Disease Mutation Genotyping

Not Applicable

Completed

Conditions: Dent Disease

Interventions: Other: Genetic Analysis

First Posted Date: 2013-02-05

Last Posted Date: 2020-04-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 180

Registration Number: NCT01783795

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Immobilization Versus Immediate Motion After Anterior Submuscular Ulnar Nerve Transposition

Not Applicable

Withdrawn

Conditions: Cubital Tunnel Syndrome

Interventions: Procedure: Immobilization followed by protected range of motion
Procedure: Immediate range of motion

First Posted Date: 2013-02-01

Last Posted Date: 2014-12-02

Lead Sponsor: Mayo Clinic

Registration Number: NCT01781494

The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms

Phase 1

Completed

Conditions: Alzheimer's Disease (AD)

Interventions: Drug: lorazepam

First Posted Date: 2013-01-31

Last Posted Date: 2016-11-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 57

Registration Number: NCT01780519

Locations: 🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States

Cough Reflex Sensitivity and Bronchial Hyper-responsiveness

Completed

Conditions: Chronic Cough
Broncho-hyperreactivity
Gastroesophageal Reflux Disease

Interventions: Procedure: Cough Reflex Sensitivity
Procedure: Methacholine Challenge

First Posted Date: 2013-01-29

Last Posted Date: 2017-02-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT01777867

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy